AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$323M |
| 2 |
Visa
V
|
+$288M |
| 3 |
RTX Corp
RTX
|
+$262M |
| 4 |
Aecom
ACM
|
+$250M |
| 5 |
Automatic Data Processing
ADP
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$468M |
| 2 |
RTN
Raytheon Company
RTN
|
+$349M |
| 3 |
JPMorgan Chase
JPM
|
+$280M |
| 4 |
Alibaba
BABA
|
+$206M |
| 5 |
Ulta Beauty
ULTA
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.48% |
| 2 | Healthcare | 16.91% |
| 3 | Financials | 12.2% |
| 4 | Consumer Discretionary | 11.74% |
| 5 | Communication Services | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BAF
2951
DELISTED
BLACKROCK MUNICIPAL INCOME INVESTMENT QUALITY TRUST
BAF
| $244K | ﹤0.01% |
17,968
| – | – |
|
2952
The Joint Corp
JYNT
$121M
| $240K | ﹤0.01% |
+15,700
| New | +$206K |
|
2953
Westwood Holdings Group
WHG
$187M
| $239K | ﹤0.01% |
15,197
+3,500
| +30% | +$66.6K |
|
2954
ACNB Corp
ACNB
$644M
| $238K | ﹤0.01% |
9,100
-577
| -6% | -$14.3K |
|
|
KALV
2955
DELISTED
KalVista Pharmaceuticals
KALV
| $238K | ﹤0.01% |
19,700
+7,400
| +60% | +$78.7K |
|
2956
Red Robin
RRGB
$132M
| $238K | ﹤0.01% |
23,318
+8,480
| +57% | +$107K |
|
2957
eGain
EGAN
$182M
| $236K | ﹤0.01% |
21,200
+5,400
| +34% | +$49.1K |
|
2958
LCNB Corp
LCNB
$290M
| $236K | ﹤0.01% |
14,800
+2,000
| +16% | +$27.6K |
|
|
PFBI
2959
DELISTED
Premier Financial Bancorp
PFBI
| $235K | ﹤0.01% |
18,312
+2,600
| +17% | +$32.2K |
|
2960
Ceco Environmental
CECO
$4.2B
| $234K | ﹤0.01% |
35,500
+3,900
| +12% | +$21.1K |
|
2961
Clarus
CLAR
$126M
| $232K | ﹤0.01% |
20,080
+4,812
| +32% | +$48.9K |
|
|
CWBC
2962
Community West Bancshares
CWBC
$682M
| $232K | ﹤0.01% |
15,100
+2,800
| +23% | +$38.7K |
|
2963
HF Foods Group
HFFG
$82.9M
| $230K | ﹤0.01% |
25,400
+11,400
| +81% | +$83K |
|
|
BMY.RT
2964
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $230K | ﹤0.01% |
+64,350
| New | +$232K |
|
2965
Keros Therapeutics
KROS
$204M
| $229K | ﹤0.01% |
+6,100
| New | +$188K |
|
2966
Spyre Therapeutics
SYRE
$8.64B
| $229K | ﹤0.01% |
992
+592
| +148% | +$113K |
|
2967
Vanguard Russell 2000 ETF
VTWO
$17.4B
| $229K | ﹤0.01% |
+3,968
| New | +$210K |
|
|
NETI
2968
DELISTED
Eneti Inc.
NETI
| $229K | ﹤0.01% |
14,960
+8,660
| +137% | +$170K |
|
|
CBMG
2969
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $229K | ﹤0.01% |
+15,300
| New | +$219K |
|
|
AUD
2970
DELISTED
Audacy, Inc.
AUD
| $228K | ﹤0.01% |
165,200
+18,500
| +13% | +$26.2K |
|
|
HMNF
2971
DELISTED
HMN Financial Inc
HMNF
| $227K | ﹤0.01% |
15,551
| – | – |
|
2972
Oil-Dri
ODC
$1.43B
| $226K | ﹤0.01% |
+13,000
| New | +$225K |
|
|
AGRX
2973
DELISTED
Agile Therapeutics
AGRX
| $226K | ﹤0.01% |
+41
| New | +$213K |
|
|
IIN
2974
DELISTED
IntriCon Corporation
IIN
| $226K | ﹤0.01% |
16,700
+1,800
| +12% | +$22.9K |
|
2975
GrowGeneration
GRWG
$90.1M
| $225K | ﹤0.01% |
+32,900
| New | +$181K |
|
Similar funds
AllianceBernstein's Q2 2020 Portfolio in Review
As of Q2 2020, AllianceBernstein held 3,348 positions worth $170B, up 22% from $139B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q2 2020 filing shows 216 new, 1,761 increased, 1,112 reduced and 154 closed positions. Its largest new stake was Otis Worldwide: 6,236,857 shares worth $355M. The largest sale was Berkshire Hathaway Class B, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q2 2020 buy was Otis Worldwide: 6,236,857 shares worth $355M.
- AllianceBernstein added most to Visa in Q2 2020, an estimated $288M increase.
- AllianceBernstein's biggest Q2 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $468M.
- AllianceBernstein fully exited Raytheon Company in Q2 2020, selling an estimated $349M.
- AllianceBernstein's ten largest holdings make up 23% of its $170B portfolio in Q2 2020.
- AllianceBernstein opened 216 new positions and closed 154 in Q2 2020.
- AllianceBernstein's portfolio value rose 22% quarter-over-quarter to $170B.
Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.